H46.3

Clinical Causes: Prolonged use of certain medications, such as methotrexate, amiodarone, or ethambutol Exposure to toxic chemicals like lead, arsenic, or mercury Heavy alcohol consumption over time Use of recreational drugs that are neurotoxic Heavy metal poisoning Environmental exposure to industrial toxins Nutritional deficiencies that impair nerve health

Key Symptoms: Gradual or sudden decline in central or peripheral vision Color vision impairment, especially difficulty distinguishing reds and greens Blurred vision or seeing a hazy or foggy field Increased sensitivity to light (photophobia) Presence of visual field defects, such as blind spots Possible eye pain or discomfort (less common)

Diagnosis Path: Diagnosis involves a comprehensive eye examination, including visual acuity tests and visual field assessments. Doctors may perform optic nerve imaging, like optical coherence tomography (OCT), to evaluate nerve health. Blood tests to identify toxic substances or nutritional deficiencies, along with a review of medication history, are also essential. Occasionally, nerve conduction studies or magnetic resonance imaging (MRI) may be used to rule out other neurological causes of vision loss.

Treatment Protocols: Management of toxic optic neuropathy primarily focuses on removing or reducing exposure to the toxic agent. If medication toxicity is suspected, discontinuing or switching drugs under medical supervision is advised. Supportive care may include nutritional supplementation if deficiencies are found. In some cases, therapy to promote nerve regeneration is considered, but the effectiveness varies. Early detection and intervention are crucial, as damage may be irreversible if left untreated for too long.